Themes US R&D Champions ETF
USRD
1 hedge funds and large institutions have $100 invested in Themes US R&D Champions ETF in 2025 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
0.12% less ownership
Funds ownership: 0.13% → 0.01% (-0.12%)
92% less capital invested
Capital invested by funds: $1.23K → $100 (-$1.13K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$1.15K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $100 | -$1.15K | -35 | -92% |
|
USRD Hedge Fund Activity: Q3 2025 in Review
1 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Themes US R&D Champions ETF (USRD) for Q3 2025, worth a combined $100 — down 92% from $1.23K a quarter earlier.
Fund positioning in USRD was balanced in Q3 2025: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was UBS Group, cutting an estimated $1.15K.
- 1 institutional investor held Themes US R&D Champions ETF (USRD) as of Q3 2025, unchanged from Q2 2025.
- Funds reported $100 of Themes US R&D Champions ETF stock for Q3 2025, down 92% quarter-over-quarter.
- 0 funds opened new Themes US R&D Champions ETF positions in Q3 2025 and 0 closed out.
- The largest Themes US R&D Champions ETF seller in Q3 2025 was UBS Group, an estimated $1.15K sold.
Based on aggregated 13F filings for Q3 2025.